Quality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugs.

Autor: de Araújo AA; Department of Biophysical and Pharmacology, Universidade Federal do Rio Grande do Norte (UFRN), Natal, RN, Brazil, aurigena@ufrnet.br., de Araújo Dantas D, do Nascimento GG, Ribeiro SB, Chaves KM, de Lima Silva V, de Araújo RF Jr, de Souza DL, de Medeiros CA

Publikováno v: The Psychiatric quarterly [Psychiatr Q] 2014 Sep; Vol. 85 (3), pp. 357-67.

The prevalence of constipation in adult psychiatric out-patients on clozapine treatment at a regional public hospital in Hong Kong.

Autor: Lam EW; Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China., Ip BP; Department of Psychiatry, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.

Publikováno v: Human psychopharmacology [Hum Psychopharmacol] 2024 Sep; Vol. 39 (5), pp. e2897. Date of Electronic Publication: 2024 Apr 11.

Health equity and the usage of atypical antipsychotics within the Brazilian national health system: findings and implications.

Autor: Zuppo, Isabella de Figueiredo, Ruas, Cristina Mariano, de Oliveira, Helian Nunes, Godman, Brian, Castel, Saulo, Wainberg, Milton L., Reis, Edna Afonso

Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research; Aug2021, Vol. 21 Issue 4, p743-751, 9p

Impact of Severe Mental Illness on Quality of Life: Challenges for Research and Practices

Autor: Ritsner, Michael S.

This monograph deals with the health-related quality of life deficit (QOL) of people with severe mental disorders, focusing on issues related to its concept, characteristic profile, on developing the Distress/Protection Vulnerability Quality of Life